SCHEMBL6938533

SCHEMBL6938533

C/C=C\Oc1cccc(C(=O)c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.53
ATM Q13315 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
STS P08842 5/20 0.53
SRD5A2 P31213 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
PBRM1 Q86U86 1/20 0.46
ALDH1A1 P00352 2/20 0.45
ELANE P08246 2/20 0.45
AKR1C3 P42330 1/20 0.45
LMNA P02545 2/20 0.44
MAPK1 P28482 2/20 0.44
MAPT P10636 2/20 0.44
PTGS1 P23219 2/20 0.44
CXCR1 P25024 2/20 0.44
CXCR2 P25025 2/20 0.44
PTGS2 P35354 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6938536 1.00 L3MBTL1 (0.53) L3MBTL1ATMTDP1STSSRD5A2
SCHEMBL28459005 0.87 AKR1C3 (0.56) KMT2AAKR1C3KDM4E
SCHEMBL28649673 0.85 ELANE (0.58) L3MBTL1STSSRD5A2ALDH1A1ELANE
SCHEMBL757838 0.81 SMN1; SMN2 (0.51) L3MBTL1MEN1KMT2AALDH1A1LMNA
SCHEMBL757114 0.81 SMN1; SMN2 (0.51) L3MBTL1MEN1KMT2AALDH1A1LMNA
SCHEMBL757113 0.81 SMN1; SMN2 (0.51) L3MBTL1MEN1KMT2AALDH1A1LMNA
SCHEMBL5245757 0.80 L3MBTL1 (0.57) L3MBTL1ATMTDP1STSSRD5A2
SCHEMBL28064519 0.79 LMNA (0.67) L3MBTL1ATMMEN1KMT2AALDH1A1
SCHEMBL30414806 0.78 MEN1 (0.69) L3MBTL1ATMTDP1STSMEN1
SCHEMBL755443 0.78 MEN1 (0.69) L3MBTL1ATMTDP1STSMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888278-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2003-07-23 EP disclosed
EP-0888278-A4 ANTIDIABETIC AGENTS MERCK & CO INC (US) 1999-06-30 EP disclosed
EP-0888278-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-01-07 EP disclosed
WO-1997028115-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed